Preventive medicine reports · 2025
Point-of-care testing of cardiovascular risk factors in Viennese community pharmacies: A cross-sectional study.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Bischof Thorsten, Mair Viktoria, Schmidt-Ilsinger Alexander, Saiko Philipp, Ergott-Badawi Susanne, Jilma Bernd, Deibl Stefan, Schoergenhofer Christian
Аннотация
OBJECTIVE: Despite being the leading contributor to global mortality, cardiovascular diseases remain undetected in many individuals at-risk. The aim of this study was to evaluate the proportion of individuals with unrecognised cardiovascular risk factors among all-comers in community pharmacies.
METHODS: This cross-sectional study conducted in 47 Viennese community pharmacies between November 1, and December 31, 2024, screened adults for cardiovascular risk factors using point-of-care testing (HbA1c, lipid profile) and the age-appropriate Systematic Coronary Risk Evaluation 2. An optional follow-up after three months assessed whether medical referral occurred and pharmacotherapy was initiated or changed. Patients treated for diabetes or hyperlipidaemia were excluded.
RESULTS: Among 445 individuals, 51 % were identified with increased cardiovascular risk factors. Of these, 151 agreed to participate in the follow-up, in which 66 % were successfully contacted. The respondents reported an attendance rate of 57 % and 43 % received new or modified pharmacotherapy.
CONCLUSIONS: Community pharmacy-based screening proved effective, identifying numerous previously undiagnosed individuals with increased cardiovascular risk, which is especially remarkable within a comprehensive healthcare system. However, follow-up rates remained low, indicating a gap between risk detection and medical action. A stronger integration of screening interventions with primary care and follow-up pathways with medical institutions may enhance the effectiveness.
METHODS: This cross-sectional study conducted in 47 Viennese community pharmacies between November 1, and December 31, 2024, screened adults for cardiovascular risk factors using point-of-care testing (HbA1c, lipid profile) and the age-appropriate Systematic Coronary Risk Evaluation 2. An optional follow-up after three months assessed whether medical referral occurred and pharmacotherapy was initiated or changed. Patients treated for diabetes or hyperlipidaemia were excluded.
RESULTS: Among 445 individuals, 51 % were identified with increased cardiovascular risk factors. Of these, 151 agreed to participate in the follow-up, in which 66 % were successfully contacted. The respondents reported an attendance rate of 57 % and 43 % received new or modified pharmacotherapy.
CONCLUSIONS: Community pharmacy-based screening proved effective, identifying numerous previously undiagnosed individuals with increased cardiovascular risk, which is especially remarkable within a comprehensive healthcare system. However, follow-up rates remained low, indicating a gap between risk detection and medical action. A stronger integration of screening interventions with primary care and follow-up pathways with medical institutions may enhance the effectiveness.